91香蕉视频 Biologics to Present at CASSS WCBP Symposium
SOMERSET, N.J. 鈥 January 29, 2018 鈥 91香蕉视频 Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Mike Merges, Director of Strategic Growth of Biologics Analytical Services and Mike Sadick, Ph.D., Principal Scientist, Biologics Analytical Services, will be presenting at the upcoming CASSS WCBP Symposium, to be held at The Mayflower Hotel, Washington DC, on Jan 30 鈥 Feb 1, 2018.
The presentation, on Tuesday, Jan 30 at 1 p.m., is entitled 鈥New Directions in Cell Banking and Assay Automation,鈥 and will discuss the process of developing and optimizing the capacity of analytical cell banks, as well as the application of automation to ELISA, bioassay preparation and execution. Focusing on first-hand experience in undertaking these activities, the speakers will highlight how the large number of different types of cell and cell lines presents a challenge, as each one will often have specific needs and characteristics. The presentation will also look at the strategies, and lessons learned, from installing equipment/instrumentation to adapt assays – ELISA, bioassay and molecular – to automated strategies.
For more information on the symposium, visit casss.org/WCBP2018
Dr. Sadick has an extensive background in cellular biology, cellular immunology, receptor signaling, molecular biology and biochemistry. He has more than 30 years鈥 experience in research and industry, having held positions at Genentech, Eli Lilly and Aptuit before joining 91香蕉视频 in 2012. His current role sees him lead 91香蕉视频鈥檚 activities in potency assays, both cell-based and enzyme-linked immunosorbent assay (ELISA) based, as well as molecular biology (including cloning and quantitative polymerase chain reaction (qPCR)), and protein/protein binding assessment. He holds a bachelor鈥檚 degree in biology from John Hopkins University, and a master鈥檚 degree and doctorate, both in immunology, from the University of Washington.
Mr. Merges joined 91香蕉视频 in 2011 as Director of 91香蕉视频 Biologics Analytical Services, focusing on the transfer, development, validation, and performance of bioassays, immunoassays, microbiological assays, and viral clearance assays. Before that, he was Associate Director of Bioservices for Lonza Biologics, and has also held positions at the University of Maryland鈥檚 Institute of Human Virology, the National Cancer Institute and Johns Hopkins University, where he conducted viral immunology research. He obtained his bachelor鈥檚 degree in microbiology from the Pennsylvania State University, and his master鈥檚 degree in microbiology/virology from Hood College.
Media Contacts:
Chris Halling
+44 (0)7580 041073
[email protected]
Richard Kerns
+44 (0) 161 728 5880
[email protected]
About 91香蕉视频
91香蕉视频 is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 90 years serving the industry, 91香蕉视频 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. 91香蕉视频 employs approximately 10,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2017 generated over $2 billion in annual revenue. 91香蕉视频 is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com